TMF retention SOP – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Tue, 16 Sep 2025 05:08:30 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for TMF Archiving and Retention (Multi-Region Rules) https://www.clinicalstudies.in/sop-for-tmf-archiving-and-retention-multi-region-rules/ Tue, 16 Sep 2025 05:08:30 +0000 ]]> https://www.clinicalstudies.in/?p=7021 Read More “SOP for TMF Archiving and Retention (Multi-Region Rules)” »

]]>
SOP for TMF Archiving and Retention (Multi-Region Rules)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-archiving-and-retention-multi-region-rules”
},
“headline”: “SOP for TMF Archiving and Retention (Multi-Region Rules)”,
“description”: “This SOP defines standardized processes for archiving and retaining Trial Master Files (TMF/eTMF) in compliance with multi-regional requirements including FDA, EMA, CDSCO, and WHO, covering secure storage, retention timelines, access, retrieval, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for TMF Archiving and Retention (Multi-Region Rules)

SOP No. CR/OPS/080/2025
Supersedes NA
Page No. 1 of 38
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish standardized processes for archiving and retaining Trial Master Files (TMF/eTMF) in compliance with multi-regional requirements. Proper archiving ensures that essential documents are preserved, secure, accessible, and inspection-ready for the retention period defined by regulatory authorities such as FDA, EMA, CDSCO, MHRA, PMDA, and WHO.

Scope

This SOP applies to all clinical trials conducted by the sponsor or through CROs where TMF/eTMF archiving and retention obligations exist. It covers procedures for indexing, secure storage, environmental controls, access, retrieval, and compliance with country-specific retention rules.

Responsibilities

  • Sponsor: Ensures TMF/eTMF is archived and retained according to regulatory requirements.
  • TMF Administrator: Manages indexing, secure storage, and retrieval processes.
  • QA: Audits archived TMFs for integrity, security, and accessibility.
  • IT/System Administrator: Manages eTMF backup, disaster recovery, and electronic archiving compliance.
  • Vendors/Archivists: Ensure external archiving facilities meet regulatory standards.

Accountability

The sponsor is accountable for ensuring TMF/eTMF archiving complies with regional rules. TMF administrators and archivists are accountable for maintaining document security and accessibility. QA ensures independent verification.

Procedure

1. TMF Finalization
1.1 Perform final reconciliation of TMF/ISF before archiving.
1.2 Complete TMF Archiving Checklist (Annexure-1).
1.3 Ensure placeholders are resolved and QC checks completed.

2. Indexing and Preparation
2.1 Assign unique archive ID to each TMF.
2.2 Prepare TMF Archive Inventory Log (Annexure-2).
2.3 For eTMF, lock database, generate audit trail, and prepare read-only archive version.

3. Archiving Facilities
3.1 Store paper TMFs in controlled facilities with temperature 18–25°C and humidity 30–60%.
3.2 Facilities must have restricted access, fire protection, and disaster recovery systems.
3.3 For eTMFs, archive in validated systems with backup at separate geographic location.

4. Access and Retrieval
4.1 Access must be restricted to authorized personnel.
4.2 Maintain Archive Access Log (Annexure-3).
4.3 Retrieval requests must be documented and justified.

5. Retention Timelines (Examples)
5.1 FDA (21 CFR 312.57): 2 years after NDA approval or discontinuation.
5.2 EMA (Directive 2005/28/EC): 25 years for essential documents.
5.3 MHRA: Minimum 25 years.
5.4 CDSCO: Minimum 15 years.
5.5 WHO: Minimum 15 years or per product-specific requirements.

6. Transfer or Migration
6.1 Document any TMF transfer between facilities or vendors.
6.2 For eTMF migration, validate system transfer and reconcile documents.
6.3 Record details in TMF Transfer Log (Annexure-4).

7. Monitoring and Audit
7.1 QA audits archived TMFs annually for security and integrity.
7.2 Archive vendors must be qualified and re-qualified every 3 years.

Abbreviations

  • SOP: Standard Operating Procedure
  • TMF/eTMF: Trial Master File / electronic Trial Master File
  • QA: Quality Assurance
  • ISF: Investigator Site File
  • NDA: New Drug Application
  • FDA: Food and Drug Administration
  • EMA: European Medicines Agency
  • MHRA: Medicines and Healthcare products Regulatory Agency
  • CDSCO: Central Drugs Standard Control Organization
  • WHO: World Health Organization

Documents

  1. TMF Archiving Checklist (Annexure-1)
  2. TMF Archive Inventory Log (Annexure-2)
  3. Archive Access Log (Annexure-3)
  4. TMF Transfer Log (Annexure-4)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, TMF Administrator
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Quality

Annexures

Annexure-1: TMF Archiving Checklist

Item Status Remarks
TMF Reconciled Yes All documents verified
QC Performed Yes 100% check completed

Annexure-2: TMF Archive Inventory Log

Archive ID Trial ID Documents Included Location
ARCH-2025-01 CT-2025-001 Full TMF Archive Facility – Pune

Annexure-3: Archive Access Log

Date User Reason for Access Approved By
15/10/2025 QA Auditor Annual audit QA Manager

Annexure-4: TMF Transfer Log

Date Transferred From Transferred To Responsible Remarks
20/11/2025 Vendor A Vendor B TMF Admin System migration validated

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Quality

For more SOPs visit: Pharma SOP

]]>